HAVCR2 and malaria: In conclusion, Tim‐3 serves as both a promoter and a suppressor of immune responses during malaria infection, suggesting that targeting Tim‐3 and its related pathways could be a therapeutic strategy to enhance immune clearance and control the progression of malaria.